Engage Bio
mRNA Immunotherapies to Eliminate Cancer
Santa Clara, United States · Founded 2021 · $500K raised
- Headquarters
- Santa Clara, California
- Employees
- 1–10
- Founded
- 2021
- Website
- engagebio.com
- Total Funding
- $500K
- Last Round
- $500K SeedMar 2022
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Engage Bio is developing mRNA immunotherapies to defeat cancer. Our founders have deep experience in immunotherapy development, including four drugs in the clinic, and in building mRNA therapeutics platforms. Our approach is to provide cancer cells with instructions to make and gradually release our drugs within solid tumors. This local therapy allows us to eliminate tumors while sparing healthy distant tissues.
Summary
Engage Bio is a Biotech company based in Santa Clara, United States, founded in 2021. It has raised $500K in total across 1 round, most recently a $500K Seed round in Mar 2022.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2022
Similar Companies
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/engagebio"><img src="https://indexed.vc/api/badge/company/engagebio" alt="Engage Bio on Indexed.vc" width="260" height="76" /></a>